These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23410672)

  • 21. Regulation of apo A-I gene expression by fibrates.
    Staels B; Auwerx J
    Atherosclerosis; 1998 Apr; 137 Suppl():S19-23. PubMed ID: 9694537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate.
    Brouillette C; Bossé Y; Pérusse L; Gaudet D; Vohl MC
    J Hum Genet; 2004; 49(8):424-432. PubMed ID: 15249972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular effect of fenofibrate on PBMC gene transcription related to lipid metabolism in patients with metabolic syndrome.
    Moreno-Indias I; Tinahones FJ; Clemente-Postigo M; Castellano-Castillo D; Fernández-García JC; Macias-Gonzalez M; Queipo-Ortuño MI; Cardona F
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):784-790. PubMed ID: 28251701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of human apolipoprotein AI and high-density lipoprotein by fenofibrate in hapoAI and hapoAI-CIII-AIV transgenic mice.
    Srivastava RA; He S; Newton RS
    Biochim Biophys Acta; 2011 Feb; 1811(2):76-83. PubMed ID: 21081177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation at position 162 of peroxisome proliferator-activated receptor alpha does not influence the effect of fibrates on cholesterol or triacylglycerol concentrations in hyperlipidaemic subjects.
    Puckey LH; Knight BL
    Pharmacogenetics; 2001 Oct; 11(7):619-24. PubMed ID: 11668221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism.
    Luc G; Jacob N; Bouly M; Fruchart JC; Staels B; Giral P
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):452-3. PubMed ID: 15076230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrates.
    Robillard R; Fontaine C; Chinetti G; Fruchart JC; Staels B
    Handb Exp Pharmacol; 2005; (170):389-406. PubMed ID: 16596808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum.
    Fournier N; Paul JL; Atger V; Cogny A; Soni T; de la Llera-Moya M; Rothblat G; Moatti N
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2685-91. PubMed ID: 9409243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate.
    Shen J; Arnett DK; Parnell LD; Lai CQ; Straka RJ; Hopkins PN; An P; Feitosa MF; Ordovás JM
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):254-9. PubMed ID: 22075751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin and Fenofibrate Exert Opposite Effects on the Vascularization and Characteristics of Visceral Adipose Tissue in New Zealand White Rabbits.
    Mondragón-García A; Luna-Luna M; Flores-Castillo C; Aranda-Fraustro A; Carreón-Torres E; López-Olmos V; Fragoso JM; Vargas-Alarcón G; Pérez-Méndez Ó
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):559-566. PubMed ID: 31056933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment.
    Christou GA; Tellis KC; Elisaf MC; Tselepis AD; Kiortsis DN
    Hormones (Athens); 2012; 11(2):178-88. PubMed ID: 22801564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenofibrate induces a selective increase of protein-bound homocysteine in rodents: a PPARalpha-mediated effect.
    Legendre C; Caussé E; Chaput E; Salvayre R; Pineau T; Edgar AD
    Biochem Biophys Res Commun; 2002 Aug; 295(5):1052-6. PubMed ID: 12135600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of lipid lowering fibrates on P-glycoprotein activity in vitro.
    Ehrhardt M; Lindenmaier H; Burhenne J; Haefeli WE; Weiss J
    Biochem Pharmacol; 2004 Jan; 67(2):285-92. PubMed ID: 14698041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate.
    Frazier-Wood AC; Aslibekyan S; Borecki IB; Hopkins PN; Lai CQ; Ordovas JM; Straka RJ; Tiwari HK; Arnett DK
    Pharmacogenet Genomics; 2012 Oct; 22(10):750-7. PubMed ID: 22890011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypolipidemic drugs can change the composition of rat brain lipids.
    Vecka M; Tvrzická E; Stanková B; Novák F; Nováková O; Zák A
    Tohoku J Exp Med; 2004 Dec; 204(4):299-308. PubMed ID: 15572855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleiotropic effects of fenofibrate.
    Tsimihodimos V; Liberopoulos E; Elisaf M
    Curr Pharm Des; 2009; 15(5):517-28. PubMed ID: 19199978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.
    Rosenson RS
    Curr Atheroscler Rep; 2009 May; 11(3):161-4. PubMed ID: 19361346
    [No Abstract]   [Full Text] [Related]  

  • 38. Reverse cholesterol transport fluxes.
    Hellerstein M; Turner S
    Curr Opin Lipidol; 2014 Feb; 25(1):40-7. PubMed ID: 24362356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HDL: the good cholesterol].
    Petermans J
    Rev Med Liege; 1982 Jun; 37(12):481-7. PubMed ID: 6750736
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.
    Aslibekyan S; An P; Frazier-Wood AC; Kabagambe EK; Irvin MR; Straka RJ; Tiwari HK; Tsai MY; Hopkins PN; Borecki IB; Ordovas JM; Arnett DK
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):987-94. PubMed ID: 23149075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.